The Gross Margin of Intra-Cellular Therapies Inc (ITCI) is 91.63%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 91.63% |
| 2023-12-31 | 92.73% |
| 2022-12-31 | 91.85% |
| 2021-12-31 | 90.45% |
| 2020-12-31 | 91.67% |